Rosa M. Agra

Santiago De Compostela, GA, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Meteorin-like protein plasma levels are associated with worse outcomes in de novo heart failure.

Meteorin-like protein plasma levels are associated with worse outcomes in de novo heart failure.

Journal: European journal of clinical investigation

Published: August 06, 2024

Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value.

Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: May 04, 2021

Obesity-Related Genetic Determinants of Heart Failure Prognosis.

Obesity-Related Genetic Determinants of Heart Failure Prognosis.

Journal: Cardiovascular drugs and therapy

Published: June 19, 2019

The different roles for the advanced glycation end products axis in heart failure and acute coronary syndrome settings.

The different roles for the advanced glycation end products axis in heart failure and acute coronary syndrome settings.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD

Published: March 05, 2019

Nutrients restriction upregulates adiponectin in epicardial or subcutaneous adipose tissue: impact in de novo heart failure patients.

Nutrients restriction upregulates adiponectin in epicardial or subcutaneous adipose tissue: impact in de novo heart failure patients.

Journal: International journal of medical sciences

Published: September 18, 2017

Effects of dapagliflozin on human epicardial adipose tissue: modulation of insulin resistance, inflammatory chemokine production, and differentiation ability.

Effects of dapagliflozin on human epicardial adipose tissue: modulation of insulin resistance, inflammatory chemokine production, and differentiation ability.

Journal: Cardiovascular research

Published: July 04, 2017

Evolution and bad prognostic value of advanced glycation end products after acute heart failure: relation with body composition.

Evolution and bad prognostic value of advanced glycation end products after acute heart failure: relation with body composition.

Journal: Cardiovascular diabetology

Published: June 30, 2017

Omentin treatment of epicardial fat improves its anti-inflammatory activity and paracrine benefit on smooth muscle cells.

Omentin treatment of epicardial fat improves its anti-inflammatory activity and paracrine benefit on smooth muscle cells.

Journal: Obesity (Silver Spring, Md.)

Published: January 04, 2017

Research update for articles published in EJCI in 2014.

Research update for articles published in EJCI in 2014.

Journal: European journal of clinical investigation

Published: August 26, 2016

Orosomucoid as prognosis factor associated with inflammation in acute or nutritional status in chronic heart failure.

Orosomucoid as prognosis factor associated with inflammation in acute or nutritional status in chronic heart failure.

Journal: International journal of cardiology

Published: August 22, 2016

Differential association of S100A9, an inflammatory marker, and p53, a cell cycle marker, expression with epicardial adipocyte size in patients with cardiovascular disease.

Differential association of S100A9, an inflammatory marker, and p53, a cell cycle marker, expression with epicardial adipocyte size in patients with cardiovascular disease.

Journal: Inflammation

Published: April 05, 2014

Impaired adipogenesis and insulin resistance in epicardial fat-mesenchymal cells from patients with cardiovascular disease.

Impaired adipogenesis and insulin resistance in epicardial fat-mesenchymal cells from patients with cardiovascular disease.

Journal: Journal of cellular physiology

Published: December 04, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026